SARS-CoV-2 rapid tests or pregnancy tests work on a similar principle. The test line changes colour depending on whether a particular protein or hormone is present. In both cases, a lateral flow assay is used. A test in which the lateral flow of the sample fluid leads to the display of a result. This single unidirectional movement of the fluid on the paper is generated by capillary forces without mechanical or electrical assistance. This detection method is not suitable for more complex tests. Here, assays are required that allow bi-directional control of liquids, i.e. transport into and out of the test system. Until now, this has required expensive and wear-prone pumps.
Researchers led by Dr. Can Dincer from the Institute of Microsystems Engineering (IMTEK) at the University of Freiburg and Prof. Dr. Wilfried Weber from the INM - Leibniz Institute for New Materials at Saarland University in Saarbrücken and the Cluster of Excellence CIBSS - Centre for Integrative Biological Signalling Studies at the University of Freiburg have now found a solution that allows complex test designs to work without them. In the latest issue of the journal Science Advances, they present biological assays in which the mechanical pumps are replaced by light-emitting diodes (LEDs). These OptoAssays enable the bidirectional, light-induced movement of biomolecules and the reading of test results without additional mechanical washing steps.